Intellectual Property India Publishes Patent Application for 'Nlrp3 Inflammasome Inhibitor And Use Thereof' Filed by Transthera Sciences (NANJING) Inc.

MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517051414 A) filed by Transthera Sciences (NANJING) Inc., Jiangsu, China, on May 28, for 'nlrp3 inflammasome inhibitor and use thereof.'

Inventor(s) include Li, Lin; and Wu, Frank.

The application for the patent was published on June 13, under issue no. 24/2025.

According to the abstract released by the Intellectual Property India: "The present invention belongs to the technical field of medicine, relates to an NLRP3 inflammasome inhibitor and a use thereof, and specifically relates to a compound represented by a general formula (A') or a pharmaceutically acceptable salt, stereoisomer and deuterated product thereof, the definition of each group b...